Table 4.
Investigator-reported responses
| Responses | Post-ASCT (n=57) |
Day +100 post- alloSCT (n=49) |
Best response after alloSCT* (n=49) |
|---|---|---|---|
| Complete Response (N) (%) | 8 (14%) | 9 (18%) | 18 (37%) |
| Partial Response (N) (%) | 27 (47%) | 23 (47%) | 18 (37%) |
| Minimal Response (N) (%) | 3 (5%) | 2 (4%) | 4 (8%) |
| Stable Disease (N) (%) | 14 (25%) | 10 (20%) | 6 (12%) |
| Progressive Disease (N) (%) | 1 (2%) | 3 (6%) | 3 (6%) |
| Missing (N) (%) | 5 (9%) | 2 (4%) | 0 |
prior to initiation of non-protocol therapy